Pulmonary involvement in polymyositis and in dermatomyositis

Journal of Rheumatology

Volumn 25, Issue 7, 1998, Pages 1336-1343

  Marie, Isabelle ^a   Hatron, Pierre Yves ^b   Hachulla, Eric ^b   Wallaert, Benoît ^b   Michon Pasturel, Ulrique ^b   Devulder, Bernard ^b  

^a Dept de Médecine Interne Ctr Hosp Univ Rouen Boisguillaume   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Dermatomyositis; Interstitial lung disease; Polymyositis; Pulmonary involvement

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DERMATOMYOSITIS; DISEASE SEVERITY; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; INTERSTITIAL LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; POLYMYOSITIS; PRIORITY JOURNAL;

EID: 0031862360     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Dickey BF, Myers AR. Pulmonary disease in polymyositis/ dermatomyositis. Semin Arthritis Rheum 1984;14:60-76.
2. Frazier AR, Miller RD. Interstitial pneumonitis in association with polymyositis and dermatomyositis. Chest 1974;65:403-7.
3. Salmeron G, Greenberg D, Lidsky SD. Polymyositis and diffuse interstitial lung disease: a review of the pulmonary histopathologic findings. Arch Intern Med 1981;141:1005-10.
4. Tazelaar HD, Viggiano RW, Pickersgill J, Colby TV. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990;141:727-33.
5. Schwarz MI. Pulmonary and cardiac manifestations of polymyositis-dermatomyositis. J Thoracic Imaging 1992;7:46-54.
6. Benbassat J, Gefel D, Larholt K, Sukenik S, Morgenstern V, Zlotnick A. Prognostic factors in polymyositis/dermatomyositis: a computer-assisted analysis of ninety-two cases. Arthritis Rheum 1985;28:249-55.
7. Bohan A, Peter JB. Polymyositis and dermatomyositis. N Engl J Med 1975;292:344-7.
8. Quanjer PH. Clinical respiratory physiology. Standardized lung function testing. Working party report: Standardization of lung function tests. Est Bull Eur Physiopathol Respir 1983;19 Suppl 5:1-95.
9. Arsura EL, Greenberg AS. Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. Semin Arthritis Rheum 1988;18:29-37.
10. Lakhanpal S, Lie JT, Conn DL, Martin WJ II. Pulmonary disease in polymyositis/dermatomyositis: a clinicopathological analysis of 65 autopsy cases. Ann Rheum Dis 1987;46:23-9.
11. Duncan PE, Griffin JP, Garcia A, Kaplan SB. Fibrosing alveolitis in polymyositis: a review of histologically confirmed cases. Am J Med 1974;57:621-6.
12. Webb DR, Curie GD. Pulmonary fibrosis masking polymyositis: remission with corticosteroid therapy. JAMA 1972;22:1146-9.
13. Schwarz MI, Matthay RA, Sahn SA, Stanford RE, Marmorstein BL, Scheinhorn DJ. Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine 1976;55:89-104.
14. Wallaert B, Hatron PY, Grosbois JM, Tonnel AB, Devulder B, Voisin C. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage: relationship between alveolitis and subsequent changes in lung function. Am Rev Respir Dis 1986;133:574-80.
15. Crystal RG, Gadek JE, Ferrans VJ, Fulmer JD, Line BR, Hunninghake GW. Interstitial lung disease: current concepts of pathogenesis, staging, and therapy. Am J Med 1981;70:542-68.
16. Löhr HF, Böeder WO, Hermann E, et al. Interstitial alveolitis as early manifestation of anti-Jo-1 positive polymyositis. Z Rheumatol 1993;52:307-11.
17. Schumacher HR, Schimmer B, Gordon GV. Articular manifestations of polymyositis and dermatomyositis. Am J Med 1979;67:287-92.
18. Hashimoto K, Robison L, Velayos E. Dermatomyositis: electron microscopic, immunologic and tissue culture studies of paramyxovirus-like inclusions. Arch Dermatol 1971;103:120-35.
19. Hashimoto Y, Nawata Y, Kurusawa K, et al. Investigation of EB virus and cytomegalovirus in rapidly progressive interstitial pneumonitis in polymyositis/dermatomyositis by in situ hybridization and polymerase chain reaction. Clin Immunol Immunopathol 1995;77:298-306.
20. Marguerie E, Bunn CC, Beynon HLC, et al. Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. Q J Med 1990;77:1019-38.
21. Hsue YT, Paulus HE, Coulson WF. Bronchiolitis obliterans organizing pneumonia in polymyositis: a case report with longterm survival. J Rheumatol 1993;20:877-9.
22. Al-Janadi M, Smith CD, Karsh J. Cyclophosphamide treatment of interstitial pulmonary fibrosis in polymyositis/dermatomyositis. J Rheumatol 1989;16:1592-6.
23. Rowen AJ, Reichel J. Dermatomyositis with lung involvement, successfully treated with azathioprine. Respiration 1983;44:143-6.
24. Maccioni FJ, Colebatch HJH. Management of fibrosing alveolitis with polymyositis dermatomyositis. Aust NZ J Med 1990;20:806-10.
25. Gruhn WB, Diaz-Buxo JA. Cyclosporine treatment of steroid resistant interstitial pneumonitis associated with dermatomyositis/polymyositis. J Rheumatol 1987;14:1045-7.
26. Medsger TA Jr, Robinson H, Masi AT. Factors affecting survivorship in polymyositis: a life-table study of 124 patients. Arthritis Rheum 1971;14:249-58.
27. Blumbergs PC, Byrne E, Kakulas BA. Polymyositis presenting with respiratory failure. J Neurol Sci 1984;65:221-9.
28. Sano M, Suzuki M, Sato M, Sakamoto T, Uchigata M. Fatal respiratory failure due to polymyositis. Intern Med 1994;33:185-7.
29. Schiavi EA, Roncoroni AJ, Puy RJM. Isolated bilateral diaphragmatic paresis with interstitial disease: an unusual presentation of dermatomyositis. Am Rev Respir Dis 1984;129:337-9.
30. Bunch TW, Tancredi RG, Lie JT. Pulmonary hypertension in polymyositis. Chest 1981;79:105-7.
31. Caldwell IW, Artchison JD. Pulmonary hypertension in dermatomyositis. Br Heart J 1956;18:273-6.
32. Nambu Y, Mouri M, Toga H, Ohya N, Iwata T, Kobachi Y. Gender and underlying diseases affect the frequency of the concurrence of adult polymyositis/dermatomyositis and interstitial pneumonia. Chest 1994;106:1931-2.
33. Hochberg MC, Feldman D, Stevens MB. Adult onset polymyositis/dermatomyositis: an analysis of clinical and laboratory features and survival in 76 patients with a review of the literature. Semin Arthritis Rheum 1986;15:168-78.
34. Fudman EJ, Schnitzer TJ. Dermatomyositis without creatine kinase elevation: a poor prognostic sign. Am J Med 1986;80:329-32.
35. Fernandez-Sola J, Casademont J, Grau JM, Urbano-Marquez A. Normal creatine kinase activity in idiopathic inflammatory myopathy: does it have prognostic implications? J Rheumatol 1991;18:1640-1.
36. Hidano A, Torikai S, Uemura T, Shimizu S. Malignancy and interstitial pneumonia as fatal complications in dermatomyositis. J Dermatol 1992;19:153-60.
37. Bernstein RM, Morgan SH, Chapman J, et al. Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. BMJ 1984;289:151-2.